NCT02920008 2024-08-28Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid LeukemiaAstex Pharmaceuticals, Inc.Phase 3 Completed302 enrolled 23 charts
NCT02348489 2024-08-27SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission InductionAstex Pharmaceuticals, Inc.Phase 3 Completed815 enrolled 19 charts